Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Braz. j. microbiol ; 48(3): 419-426, July-Sept. 2017. tab, graf
Article in English | LILACS | ID: biblio-889135

ABSTRACT

Abstract Antibodies and antibody fragments are nowadays among the most important biotechnological products, and Pichia pastoris is one of the most important vectors to produce them as well as other recombinant proteins. The conditions to effectively cultivate a P. pastoris strain previously genetically modified to produce the single-chain variable fragment anti low density lipoprotein (-) under the control of the alcohol oxidase promoter have been investigated in this study. In particular, it was evaluated if, and eventually how, the carbon source (glucose or glycerol) used in the preculture preceding cryopreservation in 20% glycerol influences both cell and antibody fragment productions either in flasks or in bioreactor. Although in flasks the volumetric productivity of the antibody fragment secreted by cells precultured, cryopreserved and reactivated in glycerol was 42.9% higher compared with cells precultured in glucose, the use of glycerol in bioreactor led to a remarkable shortening of the lag phase, thereby increasing it by no less than thrice compared to flasks. These results are quite promising in comparison with those reported in the literature for possible future industrial applications of this cultivation, taking into account that the overall process time was reduced by around 8 h.


Subject(s)
Pichia/metabolism , Industrial Microbiology/methods , Carbon/metabolism , Single-Chain Antibodies/biosynthesis , Antibodies/metabolism , Pichia/growth & development , Pichia/genetics , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Culture Media/metabolism , Culture Media/chemistry , Single-Chain Antibodies/genetics , Fermentation , Glycerol/metabolism , Lipoproteins, LDL/immunology , Antibodies/genetics
2.
Braz. j. med. biol. res ; 47(7): 540-547, 07/2014. tab, graf
Article in English | LILACS | ID: lil-712968

ABSTRACT

Intercellular adhesion molecule-1 (ICAM-1) is an important factor in the progression of inflammatory responses in vivo. To develop a new anti-inflammatory drug to block the biological activity of ICAM-1, we produced a monoclonal antibody (Ka=4.19×10−8 M) against human ICAM-1. The anti-ICAM-1 single-chain variable antibody fragment (scFv) was expressed at a high level as inclusion bodies in Escherichia coli. We refolded the scFv (Ka=2.35×10−7 M) by ion-exchange chromatography, dialysis, and dilution. The results showed that column chromatography refolding by high-performance Q Sepharose had remarkable advantages over conventional dilution and dialysis methods. Furthermore, the anti-ICAM-1 scFv yield of about 60 mg/L was higher with this method. The purity of the final product was greater than 90%, as shown by denaturing gel electrophoresis. Enzyme-linked immunosorbent assay, cell culture, and animal experiments were used to assess the immunological properties and biological activities of the renatured scFv.


Subject(s)
Animals , Female , Humans , Male , Mice , Gene Expression/physiology , Immunoglobulin Fragments/biosynthesis , Intercellular Adhesion Molecule-1/immunology , Protein Refolding , Protein Renaturation , Single-Chain Antibodies/biosynthesis , Antigen-Antibody Complex , Anti-Inflammatory Agents/pharmacology , Antibodies, Monoclonal/biosynthesis , Cell Adhesion , Chromatography , Dialysis , Enzyme-Linked Immunosorbent Assay , Ear Auricle/drug effects , Escherichia coli/genetics , Genetic Vectors , Immunoglobulin Fragments/pharmacology , Inclusion Bodies/metabolism , Intercellular Adhesion Molecule-1/drug effects , Leukocytes, Mononuclear/metabolism , Plasmids , Protein Engineering/methods , Single-Chain Antibodies/pharmacology , Xylenes/pharmacology
3.
Journal of Huazhong University of Science and Technology (Medical Sciences) ; (6): 621-5, 2008.
Article in English | WPRIM | ID: wpr-634974

ABSTRACT

To obtain single chain variable fragment (scFv) and bivalent single chain variable fragment (bsFv) against transferrin receptor, up-stream and down-stream primers were designed according to the complementary sequences of FR1 region of variable heavy (VH) and FR4 of variable light (VL), respectively, which contained inter-linker G4S and the restriction endonuclease SfiI, AscI and NotI. Two pieces of scFv fragments were first amplified through PCR and then inserted into plasmid pAB1, which could express scFv protein once induced by IPTG in the host bacteria. To express scFv and bsFv, E. coli TG1 was cultured in LB broth and was induced by IPTG. The restriction enzyme digestion map and DNA sequencing demonstrated that scFv and bsFv genes were successfully inserted into the expression plasmid. SDS-PAGE and Western blotting revealed the protein band at 35kD and 60kD, which were consistent with the molecular weight of scFv and bsFv respectively. Flow cytometry showed that scFv and bsFv harbored the specific binding activity with TfR expressed in various tumor cells, and the avidity of bsFv was higher than that of the parent scFv.


Subject(s)
Base Sequence , Cloning, Molecular , Escherichia coli/genetics , Escherichia coli/metabolism , Genetic Vectors/genetics , Hep G2 Cells , K562 Cells , Molecular Sequence Data , Receptors, Transferrin/immunology , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/genetics , Single-Chain Antibodies/biosynthesis , Single-Chain Antibodies/genetics
SELECTION OF CITATIONS
SEARCH DETAIL